title: Distribution of alpha1-adrenoceptor subtype mRNAs in human renal cortex.
abstract: OBJECTIVE
  To determine the quantity and distribution of alpha1-adrenoceptor subtype mRNAs in human renal cortex.
  
  
  METHODS
  Specimens of renal cortex tissue were obtained at the time of radical nephrectomy or total nephroureterectomy from 46 patients (mean age 59.0 years, sd 14.7) with renal cell carcinoma, renal pelvic or ureteric tumour. Using the reverse-transcriptase polymerase chain reaction (RT-PCR), the RNase protection assay and in situ hybridization, the presentation, quantity and distribution of alpha1-adrenoceptor subtype mRNAs were determined.
  
  
  RESULTS
  Expression of the three alpha1-adrenoceptor subtype mRNAs (alpha1a, alpha1b and alpha1d) was confirmed in the arteries of the renal cortex (arciform, interlobular, arteriole), but among the three subtypes, the alpha1b was less apparent by in situ hybridization. Intense alpha1-mRNA staining was apparent especially in the smooth muscle of arterial walls. In both proximal and distal renal tubules, each of the alpha1-mRNAs was less marked in cytoplasm than in the arteries. In the glomeruli weak staining was detected in the endothelium but there was no obvious staining in the veins. RT-PCR showed all three subtypes of alpha1-adrenoceptor. The RNase protection assay showed that the predominant alpha1-adrenoceptor subtype mRNA in human renal cortex was alpha1a. However, the abundance of alpha1a-mRNA in human kidney was much less than in the prostate.
  
  
  CONCLUSIONS
  Three alpha1-adrenoceptor subtype mRNAs were recognized in human renal cortex and detected particularly in the smooth muscle of the arteries. There was more alpha1a-adrenoceptor subtype in human renal cortex than the other subtypes. It is not known how each subtype operates against adrenergic stimulation; further studies are needed to examine receptor density or receptor function.
authors.affiliation: Department of Urology, Faculty of Medicine, The University of Tokyo, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Kurooka
authors.forename: N
authors.initials: N
authors.lastname: Moriyama
authors.forename: K
authors.initials: K
authors.lastname: Nasu
authors.forename: S
authors.initials: S
authors.lastname: Kameyama
authors.forename: R
authors.initials: R
authors.lastname: Fukasawa
authors.forename: J
authors.initials: J
authors.lastname: Yano
authors.forename: K
authors.initials: K
authors.lastname: Kawabe
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D006801:Humans; D017403:In Situ Hybridization; D007672:Kidney Cortex / Q000378:metabolism*; D008875:Middle Aged; D012333:RNA, Messenger / Q000378:metabolism*; D018340:Receptors, Adrenergic, alpha-1 / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods
chemical_list: D012333:RNA, Messenger; D018340:Receptors, Adrenergic, alpha-1